FMI Anti-Obesity Therapeutics Market Forecast and Segm | Page 5

Anti-Obesity Therapeutics Market
period. The rising prevalence of the obesity due to the rapidly changing lifestyle is the leading factor
increasing the demand of the anti-obesity therapeutics and drives the global anti-obesity therapeutics
market. The Increasing consumption of the fast food and lack of exercise in the population leads to the
obesity and related disorders, propel the demand of the anti-obesity therapeutics and drives the growth
of the global anti-obesity therapeutics market. The increasing focus and expenditure on research and
development activities to enhance the anti-obesity therapeutic effectiveness and to reduce the side
effects of the drugs also augment the demand of the anti-obesity therapeutics market.
However, the side effects of the anti-obesity therapeutics such as psychiatric disorder as well as strokes
may hamper the demand of the anti-obesity therapeutics and restrain the growth of the global anti-
obesity therapeutics market. The negative perception about the anti-obesity therapeutics among the
health professionals due to its side effects may hinder the demand of the anti-obesity therapeutics and
restrain the growth of the global anti-obesity therapeutics market.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-3205
Anti-Obesity Therapeutics Market: Regional Overview
The global anti-obesity therapeutics market is segmented into the seven regions: North America, Latin
America, Western Europe, and Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and Middle East
and Africa (MEA). The North America is dominating and contributed the leading shares to the global
©2015 Future Market Insights, All Rights Reserved
5